Analyst Upgrades

• Sapient (SAPE) to outperform from market perform at Wells Fargo.
• Kroger (KR) to buy from neutral at UBS.
• Harman (HAR) to overweight from neutral and Deutsche Bank (DB) to neutral from underweight at JPMorgan.
• Savient (SVNT) to outperform from market perform at JMP Securities.
• LabCorp (LH) to buy from hold at Deutsche Bank.
• Optimer Pharm (OPTR) and Landstar System (LSTR) to outperform from neutral at RW Baird.
• Essex Property Trust (ESS) to buy from neutral at Janney Capital.
• Tyson Foods (TSN) to neutral from sell at Goldman.
• Host Hotels (HST) to outperform from sector perform at RBC Capital.
• SPX Corp. (SPW) to outperform from market perform at FBR Capital.

Analyst Upgrades

• BB&T (BBT) was upgraded to buy from neutral at Janney Montgomery.
• Amylin (AMLN) was upgraded to outperform from market perform at Leerink.
• Wells Fargo upgraded Morton's Restaurant (MRT) to outperform from market perform.
• Check Point (CHKP) was upgraded to overweight from neutral at HSBC.
• Deutsche Bank upgraded Excel Maritime (EXM) to buy from hold.
• JinkoSolar (JKS) was upgraded to buy from hold at Auriga.
• Piper Jaffray upgraded Compellent (CML) to overweight from neutral.
• BofA/Merrill upgraded Crane (CR) to buy from neutral.
• Goldman upgraded Wisconsin Energy (WEC) to conviction buy from buy and American Electric (AEP) to buy from neutral.
• Motorola (MOT) was upgraded due to increasing carrier support by MKM Partners.
• Under Armour (UA) was upgraded to buy from neutral at Sterne Agee.

Today the DJIA challenged 2-year highs, on a closing basis. A rise in housing helped on the surface based on improvements year over year, although the report is in part to the comparisons from a year earlier because the levels are so low. The Yen is also reaching an inflection point at the highs against the dollar not seen in years and years, and the hope is still there is more quantitative easing to come. Earnings and ongoing merger momentum helped to keep the indexes heading in the right direction.

Here were today's unofficial closing bell levels:

Dow Jones 11,164.05 +31.49 (0.28%)
S&P 500 1,185.62 +2.54 (0.21%)
Nasdaq 2,490.85 +11.46 (0.46%)

Top Analyst Calls
Top Earnings This Week

Analyst Upgrades

• Soleil upgraded Community Health (CYH) to buy from hold based on expectations for improved 2011 demand. The firm has a $40 price target on the stock.
• Wunderlich upgraded Invesco Mortgage (IVR) to buy from hold following the company's better-than-expected Q3 dividend. The firm also raised its target price for shares to $23.50 from $21.50.
• Goldman upgraded SuccessFactors (SFSF) to conviction buy from buy, citing cloud exposure.
• Vulcan Materials (VMC) was upgraded to buy from hold at Jefferies.
• Comstock Resources (CRK) was upgraded to buy from neutral at Ladenburg.
• Trimble Navigation (TRMB) was upgraded to buy from hold at Canaccord.

Analyst Upgrades

• Credit Suisse upgraded Netflix (NFLX) to neutral from underperform and raised its price target to $140 from $90. The firm's survey work indicates Netflix's streaming offering is compelling and will continue to grow as it acquires additional streaming content.
• Barclays upgraded Ford (F) to overweight from equal weight, citing the company's earnings power, reduced cost base, expectations for a return to prior peak margins and valuation. The firm raised its target to $16 from $15.
• Merriman upgraded OpenTable (OPEN) to buy from neutral based on increased visibility into international expansion from the toptable.com acquisition and upside from its Spotlight product.
• Siemens (SI) was upgraded to conviction buy from buy at Goldman.
• Medicis (MRX) was upgraded to buy from hold at Jefferies.
• IDEX (IEX) was upgraded to outperform from neutral at Baird.

Analyst Upgrades

• UBS said Martin Marietta's (MLM) Q2 showed evidence of leverage to a recovery and the firm views risk/reward in shares as attractive. Shares were upgraded to buy from neutral, but its price target was lowered to $96 from $101.
• Soleil upgraded Regis (RGS) to buy from hold after the company said it is exploring strategic options. The firm raised its target for shares to $26 from $14.
• Wunderlich upgraded Sirius XM Radio (SIRI) to buy from hold with a $1.50 price target following the company's Q2 results. The firm believes Sirius' product continues to resonate with healthier higher-end consumers and notes that CEO Mel Karmazin said a resolution could be reached with Howard Stern by the Q3 conference call.
• Magellan Midstream (MMP) was upgraded to outperform from sector perform at RBC Capital.
• Savient (SVNT) was upgraded to neutral from underperform at BofA/Merrill.
• EMS Tech (ELMG) was upgraded to buy from hold at Needham.

All in all, this was a fairly quiet day. The markets started out soft but managed to hold up most of the day. A CEO confidence reading may have helped somewhat.

Here are today's unofficial closing bell levels:

Dow 9,858.36 +71.49 (0.73%)
S&P 500 1,071.06 +5.58 (0.52%)
Nasdaq 2,138.23 +14.30 (0.67%)

Top Analyst Upgrades
Top Analyst Downgrades
Top Day Trader Stocks
Top Market Rumors

Analyst upgrades:

• FBR Capital upgraded Talbots (NYSE: TLB) to Outperform from Market Perform as it believes the company's inventory and SG&A control should help earnings and the stock's risk/reward is compelling at current levels. The firm raised its target on shares to $7 from $5.
• ThinkEquity upgraded Human Genome (NASDAQ: HGSI) to Buy from Accumulate to reflect higher assumptions for the company's Lupus treatment Benlysta. The firm raised its target on shares to $26 from $18.
• KeyBanc upgraded Parkway Properties (NYSE: PKY) to Buy from Hold based on valuation, improving fundamentals, and stable capital position. The firm has a $17 target on the stock.
• HSBC Holdings (NYSE: HBC) was upgraded to Overweight from Neutral at JPMorgan.
• BioScrip (NASDAQ: BIOS) was upgraded to Overweight from Neutral at Piper Jaffray.
• DISH Network (NASDAQ: DISH) was upgraded to Outperform from Neutral at Credit Suisse.

Stocks surged again, setting up August to be another big month for investors. The S&P 500 cracked 1,000 for the first time this year. The Institute for Supply Management's index moved to 48.9 in July, up from 44.8 in June. A number over 50 signals growth in the manufacturing sector.

Car sales for July were fairly strong. Ford Motor Company (NYSE: F) sales moved up a little more than 2% from the same month last year. GM sales were off almost 20%, but overall the month was as strong as any in a year. Industry experts said that the "cash for clunkers" program deserved much of the credit. The Senate may not approve another $2 billion for the program which has already been passed by the House. If the bill does not make it to the President's desk this week, August could be an unpleasant month for the car companies.

All three major indexes were up more than 1%:

Dow 9,286.56 +114.95 (1.25%)
S&P 500 1,002.62 +15.14 (1.53%)
Nasdaq 2,008.61 +30.11 (1.52%)

Today had all the earmarks in line for another solid day of sell-offs, yet the markets held ground considering the tone this morning. The good news was low inflation, the lowest in over 50 years.

But agriculture stocks were hammered on overseas competitive news about weak pricing and demand. Then came a banking downgrade from the S&P playing catch-up. Despite the mixed performance at the end of the day, this felt like a win. Here are the unofficial closing bell levels:

DJIA: 8,497.18 (-7.49)
S&P 500: 910. 71 (-1.26)
NASDAQ: 1,808.06 (+11.88)

Top Analyst Calls

Analyst upgrades

• Oppenheimer upgraded Savient Pharmaceuticals (NASDAQ: SVNT) to Perform from Underperform after the FDA's Arthritis Advisory Committee voted 14-1 in favor of approving Krystexxa for gout.
• Banc of America/Merrill upgraded Texas Instruments (NYSE: TXN) to Buy from Underperform and raised its target to $27 from $18 based on expectations that margin expansion will be higher than Street expectations.
• UBS said Nvidia (NASDAQ: NVDA) has limited downside risk given the improved outlook for the graphics processor market and professional solutions business. Shares were upgraded to Neutral from Sell and its target was raised to $11.50 from $8.
• BHP Billiton (NYSE: BHP) was upgraded to Outperform from Neutral at Macquarie.
• Neutral Tandem (NASDAQ: TNDM) was upgraded to Outperform from Neutral at Baird.
• Central Garden & Pet (NASDAQ: CENT) was upgraded to Buy from Neutral at SunTrust.

Today was a negative market from the start of trading, and the economic data just confirmed the selling, as hunting for green shoots looked more like hunting for four-leaf clovers. It seems that those analysts and economists saying that the market has risen too far and too fast are getting some more ears than in recent weeks.

The housing data showed a dip after two months of rising data, and the New York Empire Manufacturing data came in weaker than expected. Even the Iran turmoil after the election failed to rally oil. Here were today's unofficial closing bell levels:

Dow 8,613.04 -186.22 (-2.12%)
S&P 500 923.81 -22.40 (-2.37%)
Nasdaq 1,816.38 -42.42 (-2.28%)

Top 10 Analyst Calls

Analyst upgrades:

• Goldman upgraded Applied Materials (NASDAQ: AMAT) to Buy from Sell and added shares to its Conviction Buy List citing valuation. The firm also upgraded the Semiconductor Capital Equipment Sector to Attractive.
  
• Morgan Keegan believes Cisco Systems (NASDAQ: CSCO) will emerge from the slowdown as a stronger company with greater market share and expansion into adjacent markets. Shares were upgraded to Outperform from Market Perform.
• Pfizer (NYSE: PFE) was upgraded to Overweight from Equal Weight at Barclays.
  
• Daimler (NYSE: DAI) was upgraded at UBS to Neutral from Sell.
• Friedman Billings upgraded Mariner Energy (NYSE: ME) to Market Perform from Underperform on valuation and the company's upcoming catalysts in the deepwater GOM.
• Swiss Reinsurance (OTC: SWCEY) was raised to Buy from Hold at Citigroup.

Analyst downgrades:

• Intel (NASDAQ: INTC) was downgraded to Neutral from Buy at Goldman.
• Deutsche Bank cut Hess Corp (NYSE: HES) and Marathon Oil (NYSE: MRO) to Hold from Buy and Suncor (NYSE: SU) and ConocoPhillips (NYSE: COP) to Sell from Hold after cutting their oil price forecast for 2009 to $60/bbl and 2010 to $58/bbl.
  
• Merrill downgraded Akzo Nobel (OTC: AKZOY) to Neutral from Buy on expectations the company's coatings end markets will worsen and chemicals division will see pressure next year.
• Monster (NASDAQ: MNST) was lowered at Citigroup to Hold from Buy.

Dendreon (NASDAQ: DNDN) expects the Independent Data Monitoring Committee (IDMC) to review in October 2008 the interim analysis of overall survival relating to the Company's Phase 3 IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment). DNDN November call option implied volatility is at 164, puts are at 195; above its 26-week average of 129 according to Track Data, suggesting larger price fluctuations.

Savient Pharma (NASDAQ: SVNT) closed at $21.95 Thursday. SVNT's Puricase (treatment for refractory gout) BLA (biologics license application) filing is expected this autumn. SVNT September and October option implied volatility is at 86, December is at 82. SVNT average option implied volatility over the last 26-weeks is 79 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

MOST NOTEWORTHY: GlaxoSmithKline, FreeSeas and SINA Corp were today's noteworthy initiations:

• ING believes GlaxoSmithKline (NYSE: GSK) should benefit from the appointment of Andrew Witty as CEO and see limited downside risks. The firm initiated shares with a Buy rating.
  
• FreeSeas (NASDAQ: FREE) was started at Oppenheimer with an Outperform rating and $8 target, as they view FREE as an early stage growth company in the smaller dry-bulk vessel segment and finds the valuation attractive at current levels.
  
• Kaufman Bros. initiated SINA Corp (NASDAQ: SINA) with a Buy rating and $4.50 target, and believes China represents a compelling long-term growth opportunity.

OTHER INITIATIONS:

• Level 3 Comm (NASDAQ: LVLT) was initiated with a Underperform rating at Wachovia.
  
• Jefferies assumed Savient Pharma (NASDAQ: SVNT) with a Buy rating and $30 target.
  
• Lehman initiated Brown & Brown (NYSE: BRO) with an Underweight rating.